Menu
Back to Journals » OncoTargets and Therapy » Volume 10
Review
Emerging treatments for HER2-positive early-stage breast cancer: focus on neratinib
| Total article views | HTML views | PDF downloads | Totals | ||
|---|---|---|---|---|---|
| 14,522 | Dovepress* | 12,522+ | 1,308 | 13,830 | |
| PubMed Central* | 2,000 | 802 | 2,802 | ||
| Totals | 14,522 | 2,110 | 16,632 | ||
| *Since 10 July 2017 | |||||
View citations on PubMed Central and Google Scholar